Search

everythinglearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The article explains how to diagnose and manage certain types of scarring hair loss.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Yellow dots in hair and scalp examinations are important for diagnosing different scalp conditions.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.